Common knowledge in preventing small cell lung cancer can extend life span

Small cell lung cancer is endangering our human health. Male patients account for the majority because they always smoke. Common sense of prevention of small cell lung cancer can prolong life, which is a very scientific truth. So let's find out how to prevent it to prolong the life of lung cancer patients.

How long a patient with small cell lung cancer can live depends on the condition and treatment. Generally, patients with small cell lung cancer can live for about 1 year after treatment. If the patient takes good care of his body during treatment, his life can be greatly prolonged. Patients with small cell lung cancer should cooperate with doctors for treatment in a timely manner. During the treatment, the body's immunity will decline seriously. It is recommended to supplement selenium to improve immunity and achieve the effect of conditioning the body.

Selenium can effectively repair cells damaged by chemotherapy, restore cell function, strengthen metabolism, eliminate chemotherapy drug toxins, and reduce chemotherapy side effects. Patients can usually supplement selenium by taking Selenium Weikang chewable tablets. The malt selenium contained in Selenium Weikang chewable tablets is currently an advanced selenium supplement. Most of the malt selenium molecules can be absorbed by the body, and the selenium supplement conversion rate is high. Patients should actively cooperate with doctors for treatment and control the disease in time, and patients are likely to prolong their lives.

New therapy that is expected to cure tumors - biological immunotherapy technology

In clinical practice, biological immunotherapy technology is often used in combination with surgery, radiotherapy or chemotherapy to achieve therapeutic effects that cannot be achieved by a single therapy. What is the best way to treat postoperative recurrence of esophageal cancer? The application of biological immunotherapy technology after surgery can effectively clean up residual micro-lesions, thereby reducing the risk of postoperative recurrence of cancer patients and improving survival rates. During radiotherapy and chemotherapy, many patients have low sensitivity to radiotherapy and chemotherapy and cannot achieve the desired therapeutic effect. Some patients have poor body tolerance and cannot withstand more serious toxic side effects. These two problems can be effectively solved by combining biological immunotherapy technology. It can not only improve the sensitivity of patients to radiotherapy and chemotherapy, and increase the ability of biological immunotherapy technology to kill cancer cells, but also greatly reduce the toxic side effects of radiotherapy and chemotherapy, so that the quality of life of patients is improved.

Other factors affecting patient survival

Physical condition: Of course, the life span after surgery is related to the patient's physical function to a certain extent. This is because the body of cancer patients is severely damaged after surgery or long-term radiotherapy and chemotherapy, and their immunity is low. At this time, the remaining and latent tumor cells in the body are particularly prone to resurgence and cause recurrence and metastasis.

Mentality: Maintaining a good mentality in the face of cancer and actively cooperating with surgical treatment have an important impact on life expectancy after cancer surgery.